B-hCD20 mice

C57BL/6N-Ms4a1tm2(MS4A1)Bcgen/Bcgen • 111231

B-hCD2 mice
B-hCD20/hBCMA mice

B-hCD20 mice

Product nameB-hCD20 mice
Catalog number111231
Strain nameC57BL/6N-Ms4a1tm2(MS4A1)Bcgen/Bcgen
Strain backgroundC57BL/6N
NCBI gene ID12482
AliasesMS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Physiological data

Posters

View All

    Publication

      Description
      • CD20 is a marker of B cells, and it begins to express in Pre-B cells and loses expression after differentiating into plasma cells. CD20 is expressed on the surface of normal and about 95% malignant B lymphocytes, but not expressed in hematopoietic stem cells, plasma cells, or other normal tissues. CD20 is regarded as an ideal target for the treatment of B-cell lymphoma and autoimmune diseases.
      • The coding region genome of mouse Cd20 gene was replaced by human CD20 coding region in B-hCD20 mice.
      • Human CD20 were only detectable in homozygous B-hCD20 mice. Humanization of CD20 does not change the overall frequency or distribution of immune cell types in the spleen, blood, or lymph nodes. Humanized of CD20 does not change the blood cell composition and morphology, ALT, or AST levels or health of liver.
      • This product is used for pharmacodynamics and safety evaluation of B-cell lymphoma and autoimmune diseases.
      Targeting strategy

      Gene targeting strategy for B-hCD20 mice.
      The exons 2-7 of mouse Cd20 gene that encode the whole molecule (ATG to STOP codon) are replaced by human counterparts in B-hCD20 mice. The promoter, 5’UTR, and 3’UTR region of the mouse gene are retained. The human CD20 expression is driven by endogenous mouse Cd20 promoter, while mouse Cd20 gene transcription and translation will be disrupted.

      mRNA expression analysis

      Species specific analysis of CD20 gene expression in wild-type C57BL/6 mice and homozygous humanized B-hCD20 mice by RT-PCR.
      Splenocytes were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hCD20 mice (H/H). Mouse CD20 mRNA was detectable only in wild-type C57BL/6 mice. Human CD20 mRNA was detectable only in homozygous B-hCD20 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in the spleen

      Strain specific CD20 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hCD20 mice by flow cytometry.
      Splenocytes were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hCD20 mice (H/H). Protein expression was analyzed with anti-mouse CD20 antibody (Biolegend, 152107) and anti-human CD20 antibody (Biolegend, 302305) by flow cytometry. Mouse CD20 was only detectable in wild-type C57BL/6 mice. Human CD20 was exclusively detectable in homozygous B-hCD20 mice, but not in wild-type C57BL/6 mice.

      Frequency of leukocyte subpopulations in the spleen

      Frequency of leukocyte subpopulations in the spleen by flow cytometry.
      Splenocytes were isolated from wild-type C57BL/6 mice and homozygous B-hCD20 mice (female, 9-week-old, n=3). A. Flow cytometry analysis of the splenocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hCD20 mice were similar to those in C57BL/6 mice, demonstrating that the humanization of CD20 does not change the frequency or distribution of these cell types in the spleen. Values are expressed as mean ± SEM.

      Frequency of leukocyte subpopulations in the blood

      Frequency of leukocyte subpopulations in the blood by flow cytometry.
      Blood cells were isolated from wild-type C57BL/6 mice and homozygous B-hCD20 mice (female, 9-week-old, n=3). A. Flow cytometry analysis of the blood cells was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hCD20 mice were similar to those in C57BL/6 mice, demonstrating that the humanization of CD20 does not change the frequency or distribution of these cell types in the blood. Values are expressed as mean ± SEM.

      Frequency of leukocyte subpopulations in the lymph node

      Frequency of leukocyte subpopulations in the lymph node by flow cytometry.
      Leukocytes were isolated from wild-type C57BL/6 mice and homozygous B-hCD20 mice (female, 9-week-old, n=3). A. Flow cytometry analysis of the leukocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, CD4+ T cells, CD8+ T cells and Tregs in B-hCD20 mice were similar to those in C57BL/6 mice, demonstrating that the humanization of CD20 does not change the frequency or distribution of these cell types in the lymph node. Values are expressed as mean ± SEM.

      Hematology analysis

      Complete blood count (CBC) of B-hCD20 mice. Values are expressed as mean ± SD.

      Biochemistry analysis

      Biochemical test of B-hCD20 mice. Values are expressed as mean ± SD.